Neurogene Inc. (NGNE)
NASDAQ: NGNE · Real-Time Price · USD
38.60
+0.99 (2.63%)
At close: Sep 4, 2026, 4:00 PM EDT
38.12
-0.48 (-1.24%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Neurogene Employees
Neurogene had 131 employees as of December 31, 2025. The number of employees increased by 24 or 22.43% compared to the previous year.
Employees
131
Change (1Y)
24
Growth (1Y)
22.43%
Revenue / Employee
n/a
Profits / Employee
-$848,168
Market Cap
772.44M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 131 | 24 | 22.43% |
| Dec 31, 2024 | 107 | 16 | 17.58% |
| Dec 31, 2023 | 91 | 9 | 10.98% |
| Jun 30, 2023 | 82 | - | - |
| Dec 31, 2022 | 82 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| Phathom Pharmaceuticals | 371 |
| MapLight Therapeutics | 133 |
| DBV Technologies | 126 |
| Aura Biosciences | 113 |
| Verastem | 102 |
| Assembly Biosciences | 73 |
| AgomAb Therapeutics NV | 62 |
NGNE News
- 3 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 21 days ago - Neurogene price target lowered to $65 from $70 at H.C. Wainwright - TheFly
- 21 days ago - Neurogene price target raised to $81 from $69 at Guggenheim - TheFly
- 21 days ago - Neurogene price target lowered to $166 from $180 at Canaccord - TheFly
- 27 days ago - Neurogene Slides: Corporate presentation - Filings
- 27 days ago - Neurogene reports Q2 EPS ($1.53), consensus ($1.38) - TheFly
- 27 days ago - Neurogene Reports Second Quarter 2026 Financial Results and Highlights Recent Updates - Business Wire
- 27 days ago - Neurogene Earnings release: Q2 2026 - Filings